The amino acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen

Journal of Clinical Microbiology

Volumn 45, Issue 9, 2007, Pages 2971-2978

  Tian, Yongjun ^a   Xu, Yang ^b,c   Zhang, Zhenhua ^a   Meng, Zhongji ^a   Qin, Li ^a   Lu, Mengji ^b,c   Yang, Dongliang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HEPATITIS B SURFACE ANTIGEN; NEUTRALIZING ANTIBODY;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIGENICITY; ARTICLE; CELL STRAIN HEPG2; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; HELA CELL; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; VIRUS MUTANT; WESTERN BLOTTING; WILD TYPE;

AMINO ACID SUBSTITUTION; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; EPITOPES, B-LYMPHOCYTE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; IMMUNOASSAY; PROTEIN BINDING;

EID: 34548689346     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00508-07     Document Type: Article

References (44)

1. Alexopoulou, A., G. Baltayiannis, S. Jammeh, J. Waters, S. P. Dourakis, and P. Karayiannis. 2004. Hepatitis B surface antigen variant with multiple mutations in the a determinant in an agammaglobulinemic patient. J. Clin. Microbiol. 42:2861-2865.
2. Antoni, B. A., I. Rodriguez-Crespo, J. Gomez-Gutierrez, M. Nieto, D. Peterson, and F. Gavilanes. 1994. Site-directed mutagenesis of cysteine residues of hepatitis B surface antigen. Analysis of two single mutants and the double mutant. Eur. J. Biochem. 222:121-127.
3. Ashton-Rickardt, P. G., and K. Murray. 1989. Mutations that change the immunological subtype of hepatitis B virus surface antigen and distinguish between antigenic and immunogenic determination. J. Med. Virol. 29:204-214.
4. Carman, W. F. 1997. The clinical significance of surface antigen variants of hepatitis B virus. J. Viral Hepat. 4(Suppl. 1):11-20.
5. Carman, W. F., A. R. Zanetti, P. Karayiannis, J. Waters, G. Manzillo, E. Tanzi, A. J. Zuckerman, and H. C. Thomas. 1990. Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325-329.
6. Carman, W. F., C. Trautwein, F. J. Van Deursen, K. Colman, E. Dornan, G. McIntyre, J. Waters, V. Kleim, R. Muller, H. C. Thomas, and M. P. Manns. 1996. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology 24:489-493.
7. Carman, W. F., F. J. Van Deursen, L. T. Mimms, D. Hardie, R. Coppola, R. Decker, and R. Sanders. 1997. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology 26:1658-1666.
8. Carman, W. F., A. Owsianka, L. A. Wallace, B. C. Dow, and D. J. Mutimer. 1999. Antigenic characterization of pre- and post-liver transplant hepatitis B surface antigen sequences from patients treated with hepatitis B immune globulin. J. Hepatol. 31:195-201.
9. Carman, W. F., J. Korula, L. Wallace, R. MacPhee, L. Mimms, and R. Decker. 1995. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 345:1406-1407.
10. Chen, Y.-C. J., K. Delbroock, C. Dealwis, L. Mimms, I. K. Mushahwar, and W. Mandecki. 1996. Discontinuous epitopes of hepatitis B surface antigen derived from a filamentous phage peptide library. Proc. Natl. Acad. Sci. USA 93:1997-2001.
11. Chiou, H. L., T. S. Lee, J. Kuo, Y. C. Mau, and M. S. Ho. 1997. Altered antigenicity of 'a' determinant variants of hepatitis B virus. J. Gen. Virol. 78:2639-2645.
12. Cooreman, M. P., M. H. van Rossmalen, R. te Morsche, C. M. Sunnen, E. M. de Ven, J. B. Jansen, G. N. Tytgat, P. L. de Wit, and W. P. Paulij. 1999. Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring "a" loop escape mutations. Hepatology 30:1287-1292.
13. Cooreman, M. P., G. Leroux-Roels, and W. P. Paulij. 2001. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J. Biomed. Sci. 8:237-247.
14. Ghany, M. G., B. Ayola, F. G. Villamil, R. G. Gish, S. Rojter, J. M. Vierling, and A. S. Lok. 1998. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 27:213-222.
15. Grethe, S., M. Monazahian, I. Böhme, and R. Thomssen. 1998. Characterization of unusual escape variants of hepatitis B virus isolated from hepatitis B surface antigen-negative subject. J. Virol. 72:7692-7696.
16. Günther, S., L. Fischer, I. Pult, M. Sterneck, and H. Will. 1999. Naturally occurring variants of hepatitis B virus. Adv. Virus Res. 52:25-137.
17. He, J. W., Q. Lu, Q. R. Zhu, S. C. Duan, and Y. M. Wen. 1998. Mutations in the 'a' determinant of hepatitis B surface antigen among Chinese infants receiving active postexposure hepatitis B immunization. Vaccine 16:170-173.
18. Hino, K., Y. Katoh, E. Vardas, J. Sim, K. Okita, and W. F. Carman. 2001. The effect of introduction of universal childhood hepatitis B immunization in South Africa on the prevalence of serologically negative hepatitis B virus infection and the selection of immune escape variants. Vaccine 19:3912-3918.
19. Hou, J. L., P. Karayiannis, J. A. Waters, K. X. Luo, C. S. Liang, and H. C. Thomas. 1995. A unique insertion in the S gene of surface antigen-negative hepatitis B virus Chinese carriers. Hepatology 21:273-278.
20. Hou, J., Z. Wang, J. Cheng, Y. Lin, G. K. Lau, J. Sun, F. Zhou, J. Waters, P. Karayiannis, and K. Luo. 2001. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology 34:1027-1034.
21. Hsu, H. Y., M. H. Chang, Y. H. Ni, H. H. Lin, S. M. Wang, and D. S. Chen. 1997. Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis. Hepatology 26:786-791.
22. Ireland, J. H., B. O'Donnell, A. A. Basuni, J. D. Kean, L. A. Wallace, G. K. K. Lau, and W. F. Carman. 2000. Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays. Hepatology 31:1176-1182.
23. Jaoudé, G. A., and C. Sureau. 2005. Role of the antigenic loop of the hepatitis B virus envelope proteins in infectivity of hepatitis delta virus. J. Virol. 79:10460-10466.
24. Karthigesu, V. D., L. M. Allison, M. Fortuin, M. Mendy, H. C. Whittle, and C. R. Howard. 1994. A novel hepatitis B virus variant in the sera of immunized children. J. Gen. Virol. 75:443-448.
25. Kohno, H., T. Inoue, F. Tsuda, H. Okamoto, and Y. Akahane. 1996. Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B. J. Gen. Virol. 77:1825-1831.
26. Lee, P. I., L. Y. Chang, C. Y. Lee, L. M. Huang, and M. H. Chang. 1997. Detection of hepatitis B surface gene mutation in carrier children with or without immunoprophylaxis at birth. J. Infect. Dis. 176:427-430.
27. Lu, M., and T. Lorentz. 2003. De novo infection in a renal transplant recipient caused by novel mutants of hepatitis B virus despite the presence of protective anti-hepatitis B surface antibody. J. Infect. Dis. 187:1323-1326.
28. Mangold, C. M., and R. E. Streeck. 1993. Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein. J. Virol. 67:4588-4597.
29. Mangold, C. M., F. Unckell, M. Werr, and R. E. Streeck. 1995. Secretion and antigenicity of hepatitis small envelope proteins lacking cysteines in the major antigenic region. Virology 211:535-543.
30. Ni, F., D. Fang, R. Gan, Z. Li, S. Duan, and Z. Xu. 1995. A new immune escape mutant of hepatitis B virus with an Asp to Ala substitution in aa144 of the envelope major protein. Res. Virol. 146:397-407.
31. Peterson, D. L., D. A. Paul, J. Lam, I. I. Tribby, and D. T. Achord. 1984. Antigenic structure of hepatitis B surface antigen: identification of the "d" subtype determinant by chemical modification and use of monoclonal antibodies. J. Immunol. 132:920-927.
32. Protzer-Knolle, U., U. Naumann, R. Bartenschlager, T. Berg, U. Hopf, K. H. Meyer zum Buschenfelde, P. Neuhaus, and G. Gerken. 1998. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 27:254-263.
33. Qiu, X., P. Schroeder, and D. Bridon. 1996. Identification and characterization of a C(K/R)TC motif as a common epitope present in all subtypes of hepatitis B surface antigen. J. Immunol. 156:3350-3356.
34. Seddigh-Tonekaboni, S., J. A. Waters, S. Jeffers, R. Gehrke, B. Ofenloch, A. Horsch, G. Hess, H. C. Thomas, and P. Karayiannis. 2000. Effect of variation in the common "a" determinant on the antigenicity of hepatitis B surface antigen. J. Med. Virol. 60:113-121.
35. Sterneck, M., S. Gunther, J. Gerlach, N. V. Naoumov, T. Santantonio, L. Fischer, X. Rogiers, H. Greten, R. Williams, and H. Will. 1997. Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis. J. Hepatol. 26:754-764.
36. Stirk, H. J., J. M. Thornton, and C. R. Howard. 1992. A topological model for hepatitis B surface antigen. Intervirology 33:148-158.
37. Szmuness, W., C. E. Stevens, E. A. Zang, E. J. Harley, and A. Kellner. 1981. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology 1:377-385.
38. Vyas, G. N., K. R. Rao, and A. B. Ibrahim. 1972. Australia antigen (hepatitis B antigen): a conformational antigen dependent on disulfide bonds. Science 178:1300-1301.
39. Wallace, L. A., J. E. Echevarria, and W. F. Carman. 1994. Molecular characrerisation of envelope antigenic variants of hepatitis B virus from Spain. J. Infect. Dis. 170:1300-1303.
40. Waters, J. A., M. Kennedy, P. Voet, P. Hauser, J. Petre, W. Carman, and H. C. Thomas. 1992. Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. J. Clin. Investig. 90:2543-2547.
41. Weinberger, K. M., T. Bauer, S. Böhm, and W. Jilg. 2000. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J. Gen. Virol. 81:1165-1174.
42. Yamamoto, K., M. Horikita, F. Tsuda, K. Itoh, Y. Akaham, S. Yotsumoto, H. Okamoto, Y. Miyakawa, and M. Mayumi. 1994. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J. Virol. 68:2671-2676.
43. Zheng, X., R. Schirmbeck, G. Hilken, J. A. Waters, D. Yang, J. Reiman, M. Roggendorf, and M. Lu. 2002. Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization. Virology 294:342-353.
44. Zheng, X., K. M. Weinberger, R. Gehrke, M. Isogawa, G. Hilken, T. Kemper, Y. Xu, D. Yang, W. Jilg, M. Roggendorf, and M. Lu. 2004. Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity. Virology 329:454-464.